Edesa Biotech Inc (EDSA)
4.43
+0.05
(+1.14%)
USD |
NASDAQ |
Apr 23, 16:00
4.43
0.00 (0.00%)
After-Hours: 20:00
Edesa Biotech Enterprise Value: 9.625M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 9.625M |
| April 19, 2024 | 9.847M |
| April 18, 2024 | 9.561M |
| April 17, 2024 | 9.688M |
| April 16, 2024 | 9.515M |
| April 15, 2024 | 8.927M |
| April 12, 2024 | 9.942M |
| April 11, 2024 | 9.942M |
| April 10, 2024 | 10.59M |
| April 09, 2024 | 10.13M |
| April 08, 2024 | 10.48M |
| April 05, 2024 | 10.56M |
| April 04, 2024 | 10.96M |
| April 03, 2024 | 9.561M |
| April 02, 2024 | 9.688M |
| April 01, 2024 | 9.181M |
| March 28, 2024 | 9.027M |
| March 27, 2024 | 9.847M |
| March 26, 2024 | 8.80M |
| March 25, 2024 | 8.985M |
| March 22, 2024 | 9.308M |
| March 21, 2024 | 8.705M |
| March 20, 2024 | 9.434M |
| March 19, 2024 | 8.768M |
| March 18, 2024 | 9.371M |
| Date | Value |
|---|---|
| March 15, 2024 | 9.656M |
| March 14, 2024 | 9.561M |
| March 13, 2024 | 9.466M |
| March 12, 2024 | 10.16M |
| March 11, 2024 | 10.20M |
| March 08, 2024 | 10.09M |
| March 07, 2024 | 9.530M |
| March 06, 2024 | 9.418M |
| March 05, 2024 | 9.720M |
| March 04, 2024 | 10.16M |
| March 01, 2024 | 10.99M |
| February 29, 2024 | 10.38M |
| February 28, 2024 | 11.46M |
| February 27, 2024 | 11.59M |
| February 26, 2024 | 11.63M |
| February 23, 2024 | 11.56M |
| February 22, 2024 | 10.64M |
| February 21, 2024 | 12.10M |
| February 20, 2024 | 12.99M |
| February 16, 2024 | 12.76M |
| February 15, 2024 | 13.65M |
| February 14, 2024 | 13.72M |
| February 13, 2024 | 11.59M |
| February 12, 2024 | 12.26M |
| February 09, 2024 | 11.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.301M
Minimum
May 06 2019
149.96M
Maximum
Sep 20 2021
32.71M
Average
24.03M
Median
Aug 21 2019
Enterprise Value Benchmarks
| Acasti Pharma Inc | 1.674M |
| Aurinia Pharmaceuticals Inc | 379.83M |
| Lexaria Bioscience Corp | 23.70M |
| Xenon Pharmaceuticals Inc | 2.380B |
| ESSA Pharma Inc | 141.00M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.678M |
| Total Expenses (Quarterly) | 1.737M |
| EPS Diluted (Quarterly) | -0.54 |
| Earnings Yield | -59.58% |
| Normalized Earnings Yield | -116.93 |